Garry Arthur Neil

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Wayne, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sam Martin, attorney-in-fact for Garry A. Neil, M.D.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Garry Arthur Neil

Form 4 holding Chief Executive Officer, Director

Avalo Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
64,867
Estimated value
$1,686,529
Report date
28 Mar 2026
Price
$13.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Avalo Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
286,000
Estimated value
Report date
26 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Celldex Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Zura Bio Ltd

Security class
Employee Share Option (Right to Buy)
Shares / value
7,652
Estimated value
Report date
18 May 2023
Price
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount
Form 4 holding Director

ARENA PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Garry Arthur Neil

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .